Assessment of cholecalciferol and antihypertensive therapy concominant use in people with arterial hypertension

Journal Title: Біль. Суглоби. Хребет - Year 2017, Vol 7, Issue 2

Abstract

Background. The purpose of the study was to assess the effect of cholecalciferol intake at a daily dose of 2,000 IU on the serum level of 25(ОН)D total and blood pressure (BP) against the background of antihypertensive therapy in people with arterial hypertension(AH) stage II. Results. It was found that intake of diuretics (hydrochlorothiazide at a dose of 12.5–25.0 mg or indapamide 1.5 mg) as part of combination antihypertensive therapy influenced the dynamics of serum 25(OH)D (F = 5.35; p = 0.02) and its level (F = 11.8; p = 0.0009). Dynamic SBP value was highest (–27.4 ± 17.9) in the group receiving a diuretic and cholecalciferol, which was significantly (p < 0.001) different from the comparison group. In the same group, we established a correlation relationship between dynamic SBP and length of cholecalciferol intake (R = 0.42; p = 0.023). A significant influence of both cholecalciferol (F = 4,1; p = 0.046), and diuretics (F = 14.3; p = 0.0003) on dynamic SBP was established. Conclusions. Thiazide/thiazide-like diuretics negatively influenced the improvement of serum 25(OH)D level. The combined use of cholecalciferol and diuretic at a dose of 2000 IU/day in the treatment of patients with AH II degree allowed to obtain the greatest hypotensive effect on SBP without the risk of vitamin D overdosing in the body.

Authors and Affiliations

L. V. Yankouskaya, V. A. Snezhitskiy, S. A. Lyalikov

Keywords

Related Articles

Use of somatosensory memory correction for the prevention of phantom pain after lower limb amputation

Background. Phantom pain syndrome (PPS) is one of the leading syndromes that complicates the postoperative period after limb amputation. Literature data indicate that it occurs in 30–35 % of the total number of patients...

Latest findings in the field of osteoporosis: Ukrainian-Portuguese dialogue

The article is a review of the key highlights of the First Ukrainian-Portuguese conference on osteoporosis, which took place on 21–22 of June in Lisbon (Portugal). Data about epidemiology of osteoporosis and about influe...

Association between sarcopenia and hypertension, ways of mutual influence on clinical course in the elderly (literature review)

Population aging remains one of the most important demographic processes in recent decades. Representatives of the older age groups make up a significant proportion of various patient profiles. Among the specific feature...

Cataract in Inflammatory Diseases of Joints

In rheumatoid, juvenile idiopathic, chlamydial reactive, psoriatic arthritis and ankylosing spondylitis, cataract is being diagnosed in 5, 15, 6, 17 and 9 % of cases, respectively; its incidence, severity, and the maturi...

Download PDF file
  • EP ID EP218234
  • DOI 10.22141/2224-1507.7.2.2017.108695
  • Views 117
  • Downloads 0

How To Cite

L. V. Yankouskaya, V. A. Snezhitskiy, S. A. Lyalikov (2017). Assessment of cholecalciferol and antihypertensive therapy concominant use in people with arterial hypertension. Біль. Суглоби. Хребет, 7(2), 55-60. https://europub.co.uk./articles/-A-218234